NASDAQ · Medical - Healthcare Information Services

TEM (TEM) Stock

$55.06 +5.78% NASDAQ: TEM Healthcare

Valuation

MetricValue
Price$55.06
Market Cap$9.65B
P/E Ratio-341.45
P/B Ratio17.02
P/S Ratio5.62
EPS (TTM)$-1.41
52-Week High$104.32
52-Week Low$41.73
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-81.58%
ROA-9.07%
ROCE-48.68%
Gross Margin69.55%
Operating Margin-18.13%
Net Margin-22.20%
Debt/Equity1.96
Current Ratio3.14

Annual Financials (USD)

Metric20212022202320242025
Revenue$258.0M$321.0M$532.0M$693.0M$1.3B
Operating Profit$-244.0M$-265.0M$-196.0M$-691.0M$-239.0M
Net Profit$-259.0M$-290.0M$-214.0M$-706.0M$-245.0M
EPS$-1.75$-1.97$-1.73$-4.60$-1.41
Op Margin-94.5%-82.8%-36.9%-99.7%-18.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$531.0M$631.0M$564.0M$926.0M$2.3B
Total Liabilities$1.3B$1.8B$1.9B$870.0M$1.8B
Cash$278.0M$303.0M$166.0M$341.0M$605.0M
Borrowings$239.0M$433.0M$488.0M$468.0M$816.0M

Latest News

Tempus AI (TEM) On Its Personalis Deal And Whether The Bull Case Is Priced In Simply Wall St. · Jul 22, 2026 Tempus AI acquires cancer-monitoring firm Personalis for $1.5 billion Quartz · Jul 21, 2026 Tempus AI acquires Personalis in $1.5bn precision oncology-focused deal Medical Device Network · Jul 21, 2026 Tempus AI (TEM) Is Buying Personalis For $1.5 Billion To Deepen Cancer Monitoring Simply Wall St. · Jul 21, 2026 Tempus AI (TEM) Stock May Be A Bargain Despite Its 22% Slump Simply Wall St. · Jul 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-212.0M$-168.0M$-214.0M$-189.0M$-218.0M
Investing Cash Flow$-33.0M$-76.0M$-75.0M$-153.0M$-419.0M
Financing Cash Flow$-5.0M$-5.0M$-4.0M$-79.0M$-47.0M
Net Cash Flow$-236.0M$25.0M$-137.0M$175.0M$264.0M
Free Cash Flow$-224.0M$-187.0M$-249.0M$-211.0M$-239.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-523.03
EV / EBITDA-49.18
FCF Yield-2.64%
Quick Ratio3.15
Interest Coverage-3.41
Return 1Y-15.57%
Return 3Y—
Return 5Y—

Ownership

Insiders Held36.98%
Institutions Held54.61%
Institutions Float Held86.65%
Institutional HolderSharesReport Date
ARK Investment Management, LLC9,607,7452026-03-31
Blackrock Inc.8,968,3302026-03-31
BAILLIE GIFFORD & CO8,649,3562026-03-31
Softbank Group Corporation5,405,4062026-03-31
JPMORGAN CHASE & CO4,933,1932026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDSX $20.38 -3.09% -2.82 $165.90M 0.00%
BLLN $127.98 +1.51% 174.50 $5.89B 0.00%
DGXQuest Diagnostics Incorporated $235.90 +1.75% 21.70 $26.04B 1.68%
GHGuardant Health, Inc. $145.13 -1.49% -43.46 $19.24B 0.00%
ILMNIllumina, Inc. $189.61 -2.31% 26.54 $28.69B 0.00%

About TEM

TEM is led by CEO Eric Lefkofsky, employs 3,800 people, headquartered in Chicago, US, publicly traded since 2024.

TEM stock trades at $55.06 with a market capitalization of $9.65B. The stock is valued at a price-to-earnings (P/E) ratio of -341.45, price-to-book of 17.02, price-to-sales of 5.62. Over the past 52 weeks the stock has ranged between $41.73 and $104.32, and currently trades 47.2% below its 52-week high.

On profitability, TEM generates a return on equity (ROE) of -81.58%, return on capital employed of -48.68%, an operating margin of -18.13%, a net profit margin of -22.20%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1226.67 +3.68% JNJ Drug Manufacturers - General $271.11 +3.33% ABBV Drug Manufacturers - General $258.92 +3.43% UNH Medical - Healthcare Plans $393.93 -0.43% MRK Drug Manufacturers - General $135.18 -0.58% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $589.04 +0.60% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $27.25 +1.41%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides